Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rockville, Maryland


Purpose:

This study is designed to assess the effects of AZD 2624 in patients with schizophrenia


Criteria:

Inclusion Criteria: - Females of non-childbearing potential - Diagnosis of Schizophrenia Exclusion Criteria: - Clinically relevant disease and /or abnormalities. - Alcohol or substance abuse not in remission - Enrollment in another investigational study within 30 days


NCT ID:

NCT00686998


Primary Contact:

Study Director
Dhaval Desai, MD
AstraZeneca


Backup Contact:

N/A


Location Contact:

Rockville, Maryland
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.